Actively Recruiting
Effects of Functional Inspiratory Muscle Training on Pulmonary Function, Muscle Thickness, and Core Performance in Patients With Bronchiectasis
Led by Elif Kabasakal · Updated on 2026-02-10
38
Participants Needed
1
Research Sites
19 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchiectasis is a chronic lung disease marked by recurring lung flare-ups, persistent cough, and mucus production. It causes permanent widening of the airways, leading to ongoing infection, inflammation, and lung damage. This condition varies widely among patients, with symptoms ranging from daily issues to occasional flare-ups. Researchers aim to study the effects of a specialized breathing muscle training called Functional Inspiratory Muscle Training (FIMT) in adults with bronchiectasis to improve lung function and overall health. The study compares two groups: one will perform 4 weeks of Inspiratory Muscle Training (IMT) followed by 4 weeks of FIMT using a breathing device, with sessions supervised both in person and online. The other group will complete 8 weeks of daily IMT with weekly face-to-face sessions and home practice monitored via messaging. Both groups use the POWERbreathe Classic Light Resistance device to strengthen respiratory muscles, with training intensity adjusted weekly based on maximal inspiratory pressure measurements. Participants will be involved for 8 weeks, undergoing various tests at the start and end of the intervention. These include lung function tests (like forced expiratory volume and capacity), muscle strength and thickness measurements, balance and endurance tests, a six-minute walk test, posture assessment, physical activity monitoring, and quality of life questionnaires. Researchers will also monitor treatment adherence and patient satisfaction throughout the study to evaluate the impact of these breathing exercises on adults with bronchiectasis.
CONDITIONS
Brief Title
Functional Inspiratory Training in Bronchiectasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 30 years
- Diagnosed with bronchiectasis
- Clinically stable condition
- Able to cooperate with study procedures
- Able to walk independently
- Volunteering to participate in the study
You will not qualify if you...
- History of acute exacerbation or hospitalization within the past 4 weeks
- Change in medical treatment within the past month
- Diagnosed balance-affecting conditions such as visual, auditory, vestibular, or musculoskeletal disorders
- Participation in supervised physiotherapy rehabilitation within the past 6 months
- History of lung or liver transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants undergo 8 weeks of inspiratory muscle training. The first 4 weeks involve Inspiratory Muscle Training (IMT) at 50% maximal inspiratory pressure, with weekly face-to-face sessions and daily home exercises. The following 4 weeks include Functional Inspiratory Muscle Training (FIMT) with a combination of face-to-face, supervised online, and unsupervised sessions using the POWERbreathe device.
Weekly face-to-face visits plus additional online supervised and unsupervised training sessions
Trial Site Locations
Total: 1 location
1
Istinye University, Istanbul,
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
E
Elif Kabasakal, MSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here